REC-994

1 paper1 finding

Outcomes

Lesion burden

downin reviews1

1 study

REC-994 decreases lesion burden.
“The β-blocker propranolol and the superoxide dismutase mimetic REC-994 have also shown effectiveness in attenuating lesion burden in preclinical studies.”
Reviewin preclinical studies
Current and Future Treatment Options for Cerebral Cavernous Malformations
Stroke (Hoboken, N.J.)22 Mar 2024

Stroke22 Mar